EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus


Gut 30(9): 1279-1284
Carbohydrate digestion and release of pancreatic polypeptide in health and diabetes mellitus
The effects of meal volume and luminal digestion of carbohydrates on the release of pancreatic polypeptide (HPP) were investigated in eight healthy subjects and in six patients who had non-insulin dependent diabetes mellitus. On one occasion each subject ingested a placebo with 200 ml water and a starch (50 g) pudding meal (400 ml) 30 minutes later. On another occasion an amylase inhibitor that retards intraluminal starch digestion was given with the water and starch. In normal subjects, water caused a moderate rise in HPP plasma levels (16.9 (10.9) pg/ml; p less than 0.02) and ingestion of starch increased HPP in a double peaked pattern. The mean increments of the peaks were 45.0 (15.2) pg/ml (p less than 0.02) and 41.1 (17.3) pg/ml (p less than 0.05), respectively. In the diabetic subjects, the HPP concentrations did not increase in response to water. After ingestion of starch the diabetics had two peaks of HPP that were similar in magnitude, but the early postprandial peak was delayed significantly compared to normal subjects (37.5 (5.1) min v 23.4 (3.9) min; p less than 0.05). The amylase inhibitor (5 or 10 g) reduced the early postprandial HPP peak by 79% (p less than 0.05) in normal subjects and 4 g of the inhibitor reduced the early HPP peak by 58% (p less than 0.05) in the diabetics. In both groups ingestion of the amylase inhibitor abolished the late HPP peak (p less than 0.05). In conclusion, carbohydrate induced HPP release is dependent on undisturbed intraluminal starch digestion.


Accession: 002042896

PMID: 2478426

DOI: 10.1136/gut.30.9.1279



Related references

The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. Regulatory Peptides 187: 42-50, 2014

The relationship of gastric gallbladder emptying and human pancreatic polypeptide release in patients with insulin dependent diabetes mellitus iddm. Gastroenterology 98(5 PART 2): A378, 1990

Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?. Pancreas 43(4): 651-656, 2014

Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus. Pancreatology 15(2): 162-166, 2015

The morphometric measurement of the weights of the pancreatic polypeptide lobe and non-polypeptide lobe of steroid diabetes mellitus. Journal of China Medical University 26(2): 130-131, 133, 1997

Response of plasma pancreatic polypeptide in diabetes mellitus. Horumon to Rinsho. Clinical Endocrinology 31(6): 499-503, 1983

Postprandial release of gastric inhibitory polypeptide (GIP) and pancreatic polypeptide in dogs with pancreatic acinar atrophy. Correction of blunted GIP response by addition of pancreatic enzymes to a meal. Digestive Diseases and Sciences 28(4): 345-349, 1983

The release of pancreatic polypeptide and the effect of exogenous rat pancreatic polypeptide on pancreatic exocrine secretion in atropinized conscious rats. Gastroenterology 92(5 PART 2): 1537, 1987

Nutrient but not volume induced pancreatic polypeptide release in humans is dependent on intact luminal digestion. Digestion 35(1): 36, 1986

Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). Hepato-Gastroenterology 35(5): 229-237, 1988